Results 211 to 220 of about 12,295 (240)

Assessing Unmet Social Needs in Multiple Sclerosis Care in Australia: A Qualitative Assessment of Feasibility, Barriers and Enablers. [PDF]

Health Expect
Hawkins MR, Learmonth YC, Weld-Blundell I, Ayton D, Haartsen J, Kavanagh A, Kalincik T, Klaic M, Marck CH.   +8 more
europepmc   +1 more source

Inherited metabolic epilepsies–established diseases, new approaches

Epilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source

Neurotechnology Governance in the United States: Gaps and Opportunities. [PDF]

Bioethics
Cabrera LY, Evereteze N, Shank EG, Wagner JK, Mekel M, McCormick JB, Wright MS.   +6 more
europepmc   +1 more source

Real world testing and cost‐effectiveness analysis of subcutaneous EEG (REAL‐ASE): Protocol for a prospective multicentre interventional trial

Epilepsia Open, EarlyView.
Abstract Objective Epilepsy is a common condition associated with significant morbidity, mortality, and costs. Poor documentation of seizures is a major challenge in epilepsy care. Objective seizure counting with mobile devices may mitigate this challenge and improve patient management.
Matthew McWilliam, Pedro F. Viana, Eren Dursun, Joe Davies, Joel S. Winston, Jessica Agren, Harutomo Hasegawa, Jonas Duun‐Henriksen, Mark P. Richardson   +8 more
wiley   +1 more source

Strategies for carbon reduction and advertising investments in partially centralized supply chains. [PDF]

PLoS One
Zhang W, Kong J, Zhao W, Liu J.
europepmc   +1 more source

Precision therapies for genetic epilepsies in 2025: Promises and pitfalls

Epilepsia Open, EarlyView.
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang, Emilio Perucca, Samuel F. Berkovic, Piero Perucca   +3 more
wiley   +1 more source

How surface texture affects consumers' willingness to pay: Evidence from smartphone covers. [PDF]

PLoS One
Kadoya Y, Khan MSR, Nabeshima H, Kuramoto Y, Kurita Y.   +4 more
europepmc   +1 more source

Neuro-insights: a systematic review of neuromarketing perspectives across consumer buying stages. [PDF]

Front Neuroergon
Gupta R, Kapoor AP, Verma HV.
europepmc   +1 more source

Quantifying and modeling fabric surface roughness discrepancy: Consistency between physical and digital textures in online shopping. [PDF]

PLoS One
Lee E, Chae Y.
europepmc   +1 more source